CTSH Stock Overview
A professional services company, provides consulting and technology, and outsourcing services in North America, Europe, and internationally.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 2/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for CTSH from our risk checks.
Cognizant Technology Solutions Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$62.32 |
52 Week High | US$0 |
52 Week Low | US$0 |
Beta | 1.05 |
11 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | 0% |
33 Year Change | 0% |
5 Year Change | 0% |
Change since IPO | 32.03% |
Recent News & Updates
Recent updates
Shareholder Returns
CTSH | CH IT | CH Market | |
---|---|---|---|
7D | 0% | 0.8% | 1.1% |
1Y | 0% | 6.2% | 8.4% |
Return vs Industry: CTSH underperformed the Swiss IT industry which returned 6.2% over the past year.
Return vs Market: CTSH underperformed the Swiss Market which returned 8.4% over the past year.
Price Volatility
CTSH volatility | |
---|---|
CTSH Average Weekly Movement | 0% |
IT Industry Average Movement | 4.6% |
Market Average Movement | 3.5% |
10% most volatile stocks in CH Market | 7.5% |
10% least volatile stocks in CH Market | 1.8% |
Stable Share Price: CTSH has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CTSH's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1988 | 336,300 | Ravi Singisetti | www.cognizant.com |
Cognizant Technology Solutions Corporation, a professional services company, provides consulting and technology, and outsourcing services in North America, Europe, and internationally. It operates through four segments: Financial Services, Health Sciences, Products and Resources, and Communications, Media and Technology. The company provides customer experience, robotic process automation, analytics, and AI services in areas, such as digital lending, fraud detection, and next generation payments; the shift towards consumerism, outcome-based contracting, digital health, delivering integrated seamless, omni-channel, and patient-centered experience; and services that drive operational improvements in areas, such as clinical development, pharmacovigilance, and manufacturing, as well as claims processing, enrollment, membership, and billing to healthcare providers and payers, and life sciences companies, including pharmaceutical, biotech, and medical device companies.
Cognizant Technology Solutions Corporation Fundamentals Summary
CTSH fundamental statistics | |
---|---|
Market cap | CHF 32.20b |
Earnings (TTM) | CHF 1.87b |
Revenue (TTM) | CHF 16.41b |
17.2x
P/E Ratio2.0x
P/S RatioIs CTSH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CTSH income statement (TTM) | |
---|---|
Revenue | US$19.27b |
Cost of Revenue | US$12.64b |
Gross Profit | US$6.63b |
Other Expenses | US$4.43b |
Earnings | US$2.20b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 4.43 |
Gross Margin | 34.39% |
Net Profit Margin | 11.39% |
Debt/Equity Ratio | 4.5% |
How did CTSH perform over the long term?
See historical performance and comparison